Skip to content

Depression: all studies

Page 866 of 1,038: studies 8,651 to 8,660 of 10,380, newest first. Back to the depression overview

Research

Process evaluation and the development of behavioural interventions to improve psychological distress among survivors of critical illness

Thorax October 18, 2018 Ann Marie Parker, Albahi M. Malik, Megan M. Hosey 4 citations

Depressive, anxiety and post-traumatic stress disorder (PTSD) symptoms are common, long-lasting and associated with worse quality of life among intensive care unit (ICU) survivors.1–4 There are few clinical trials evaluating interventions to improve these symptoms. Cox and colleagues evaluated the feasibility of a mobile mindfulness training application (App) to address psychological stress...

Adherence to a Mindfulness and Relaxation Self-Care App for Cancer Patients: Mixed-Methods Feasibility Study

JMIR mHealth and uHealth October 18, 2018 Michael Mikolasek, Claudia M Witt, Jürgen Barth 83 citations

BACKGROUND: Cancer is highly prevalent worldwide and can cause high levels of distress in patients, which is often neglected in medical care. Smartphone apps are readily available and therefore seem promising to deliver distress-reducing interventions such as mindfulness and relaxation programs. OBJECTIVE: This study aimed to evaluate the feasibility of a mindfulness and relaxation app for...

Systematic Review and Meta-analysis: Mindfulness-Based Interventions for Rheumatoid Arthritis.

Current rheumatology reports October 18, 2018 Dana D. DiRenzo, Monica Crespo-Bosque, Neda F Gould et al.

Purpose of review: To determine the efficacy of mindfulness-based interventions (MBIs) on clinical and patient-reported outcomes in rheumatoid arthritis (RA). Recent findings: We identified randomized clinical trials from inception through April 2018 from MEDLINE, PsycINFO, EMBASE, CINAHL, Web of Science, the Cochrane Library, and hand searches. After screening 338 references, we included five...

DOI: 10.1007/s11926-018-0787-4 (opens in new tab) Full text (opens in new tab) Humans Arthritis, rheumatoid Stress Rheumatoid arthritis +2

DARK Classics in Chemical Neuroscience: Phencyclidine (PCP).

ACS Chemical Neuroscience October 17, 2018 Jeanette L Bertron, Mabel Seto, Craig W Lindsley

Phencyclidine (PCP, "angel dust", an arylcyclohexylamine) was the first non-natural, man-made illicit drug of abuse, and was coined 'the most dangerous drug in America" in the late 1970s (amidst sensational horror stories of the drug's effects); however, few other illicit drugs have had such a significant and broad impact on society-both good and bad. Originally developed as a new class of...

Youth-focused group mindfulness-based intervention in individuals with early psychosis: A randomized pilot feasibility study.

Early Intervention in Psychiatry October 15, 2018 Arlene G MacDougall, Elizabeth Price, Matthew R J Vandermeer et al.

Aim: To assess the feasibility of a randomized pilot trial that evaluated the acceptability and potential clinical utility of the Mindfulness Ambassador Program (MAP), a unique, standardized 12-session facilitated group mindfulness-based intervention (MBI) for youth experiencing early psychosis. Methods: Twenty-one patients of an early psychosis intervention program were randomized to receive...

PHYTOCHEMISTRY AND PHARMACOLOGICAL PROFILE OF TRADITIONALLY USED MEDICINAL PLANT ARGYREIA SPECIOSA (LINN. F.)

Journal of Drug Delivery and Therapeutics October 15, 2018 Bhagat Singh Jaiswal, Mukul Tailang 4 citations

Argyreia speciosa (Linn.f.) (Family: Convolvulaceae, Synonyms: Argyreia nervosa) is used in the traditional Ayurvedic systems of medicine as well as in local health folklore. It is commonly known as Vidhaara in Hindi and Hawaiian Baby Woodrose and Elephant creeper in English. It is the large climber and seen throughout India up to an altitude of 500 m. A. speciosa possess various...

AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.

Biological Psychiatry October 15, 2018 Chun Yang, Shizuka Kobayashi, Kazuhito Nakao et al.

Ketamine, an N-methyl-D-aspartate receptor antagonist, exerts robust antidepressant effects in patients with treatment-resistant depression. The precise mechanisms underlying ketamine's antidepressant actions remain unclear, although previous research suggests that alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) activation plays a role. We investigated whether...

A Model of Δ9-Tetrahydrocannabinol Self-administration and Reinstatement That Alters Synaptic Plasticity in Nucleus Accumbens.

Biological Psychiatry October 15, 2018 Sade M Spencer, Daniela Neuhofer, Vivian C Chioma et al.

Cannabis is the most widely used illicit drug, but knowledge of the neurological consequences of cannabis use is deficient. Two primary components of cannabis are Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). We established a THC+CBD model of self-administration and reinstated drug seeking to determine if, similar to other addictive drugs, cannabis produces enduring synaptic changes in...

“Combing” through ADHD Symptoms Utilizing Mindful Grooming

Routledge eBooks October 10, 2018 Carlene Taylor 1 citation

Clients with attention-deficit/hyperactivity disorder (ADHD) often experience great social difficulties, emotional dysregulation and difficulty succeeding in academic and work settings. ADHD is often present with co-morbid conditions of depression and anxiety. There appears to be reasonable evidence to suggest inclusion of mindfulness practices can be beneficial to the client struggling with...

Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs

Drug and Alcohol Review October 9, 2018 F. Fernández-Calderón, C. Díaz-Batanero, Monica J Barratt et al.

Introduction and Aims: Polysubstance users are a high-risk population for negative health-related consequences. Although some studies have described harm reduction strategies adopted by polysubstance users, studies have not examined their effectiveness in minimising health-related consequences. We aimed to identify dosing-related harm reduction strategies in a sample of polysubstance-using...